Teal background image.

Empire State Development and New York Power Authority Announce Long Island's Contract Pharmacal has More Than Doubled its Workforce Since 2012

Support from Empire State Development and the New York Power Authority has helped the company add 454 jobs, invest $71 million in equipment and new facilities, and spend $18 million on R&D

Workforce has grown from 630 in 2012 to 1,400 in 2019

Empire State Development today announced that Contract Pharmacal, a family-owned company that develops, manufactures, and packages pharmaceuticals, over the counter drugs, and dietary supplements has dramatically expanded its presence on Long Island, more than doubling its workforce over the last seven years from 630 to 1,400. Over that time period, support from Empire State Development and the New York Power Authority has required the company to create 454 jobs, invest $71 million in equipment and new facilities, and spend $18 million on research and development. These projects have further strengthened Long Island’s booming pharmaceutical industry and built on Governor Cuomo’s efforts to create opportunity in every region of New York State.

Lieutenant Governor Kathy Hochul visited the Contract Pharmacal site today, touring a building under renovation thanks to state support.

Empire State Development President, CEO and Commissioner Howard Zemsky said: “Our regionally-focused economic development process invests in industry clusters that benefit from close collaboration — including pharmaceutical companies on Long Island. We are proud to see the results of our long-standing relationship with Contract Pharmacal and look forward to continuing these efforts.”

Gil C. Quiniones, NYPA President and CEO, said: “ReCharge NY has been a critical economic driver under Governor Cuomo throughout the state, including on Long Island where the power program currently supports more than 67,000 jobs. It’s great to see Contract Pharmacal’s significant success in Hauppauge during its participation in ReCharge NY.”

“Contract Pharmacal has deep roots on Long Island and thanks to support from New York State this innovative company has seen significant job growth in recent years,” said Lieutenant Governor Kathy Hochul, who toured their facility and made today’s announcement. “Their continued expansion is part of our ongoing strategy to create good-paying jobs, invest in our workforce, and ensure a brighter economic future for Long Island and across the state.”

Mark Wolf, President of Contract Pharmacal, said: “The support of New York State has allowed us to expand and remain competitive in this highly specialized industry.”

“Contract Pharmacal started on Long Island as a small business, and for decades they have invested in Suffolk County, growing to provide quality high-skill, high-knowledge jobs for our residents,” said County Executive Steven Bellone. “Thanks to Governor Cuomo’s commitment to economic development and job growth, employment opportunities in the pharmaceutical industry have more than doubled over the course of the last 7 years and the industry remains the most significant manufacturing sector on Long Island.”

Founded in 1971, Contract Pharmacal is a family owned company that develops, manufactures and packages pharmaceuticals, over the counter drugs, and dietary supplements. Its customers include major drug companies, retailers and wholesalers. The company has been based on Long Island for more than four decades. Over the last seven years, the company has dramatically expanded its presence on Long Island, expanding from 630 employees in 2012 to 1,400 in 2019. The company now owns or leases ten different facilities in Hauppauge, totaling approximately 650,000 square feet.

To support the company’s expansion over the last seven years, Empire State Development has offered $8 million of incentives tied directly to the company creating 454 jobs, investing $71 million in equipment and new facilities, and spending $18 million on research and development. The company has far exceeded its job creation number — adding 770 jobs in that time.

The New York Power Authority currently provides the firm with 1.3 megawatts (MW) of ReCharge NY power, which provides qualifying businesses and non-profit organizations with discounted NYPA power in exchange for commitments to retain or create jobs in New York State. ReCharge NY offers up to seven-year power contracts. Half of the power—455 MW—is from NYPA’s Niagara and St. Lawrence-Franklin D. Roosevelt hydroelectric power plants, which provide some of the greenest, cleanest and lowest-cost electricity in the state. The remaining 455 MW is lower-cost power bought by NYPA on the wholesale market.

About Empire State Development

Empire State Development (ESD) is New York's chief economic development agency (www.esd.ny.gov). The mission of ESD is to promote a vigorous and growing economy, encourage the creation of new job and economic opportunities, increase revenues to the State and its municipalities, and achieve stable and diversified local economies. Through the use of loans, grants, tax credits and other forms of financial assistance, ESD strives to enhance private business investment and growth to spur job creation and support prosperous communities across New York State. ESD is also the primary administrative agency overseeing Governor Cuomo's Regional Economic Development Councils and the marketing of "I LOVE NY," the State's iconic tourism brand. For more information on Regional Councils and Empire State Development, visit www.regionalcouncils.ny.gov and www.esd.ny.gov.

About NYPA

NYPA is the largest state public power organization in the nation, operating 16 generating facilities and more than 1,400 circuit-miles of transmission lines. More than 70 percent of the electricity NYPA produces is clean renewable hydropower. NYPA uses no tax money or state credit. It finances its operations through the sale of bonds and revenues earned in large part through sales of electricity. For more information visit www.nypa.gov and follow us on Twitter @NYPAenergy, Facebook, Instagram, Tumblr and LinkedIn.

Contact:

Jack Sterne | [email protected] | (212) 803-3764

ESD Press Office | [email protected] | (800) 260-7313